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Abstract
Background: Genome wide association studies (GWAS) already have identified tens of susceptible loci for non-
syndromic cleft lip with or without cleft palate (NSCL/P). However, whether these loci associated with nonsyn-
dromic cleft palate only (NSCPO) remains unknown. 
Material and Methods: In this study, we replicated 38 SNPs (Single nucleotide polymorphisms) which has the most 
significant p values in published GWASs, genotyping by using SNPscan among 144 NSCPO trios from Western 
Han Chinese. We performed the transmission disequilibrium test (TDT) on individual SNPs and gene-gene (GxG) 
interaction analyses on the family data; Parent-of-Origin effects were assessed by separately considering trans-
missions from heterozygous fathers versus heterozygous mothers to affected offspring. 
Results: Allelic TDT results showed that T allele at rs742071 (PAX7) (p=0.025, ORtransmission=3.00, 95%CI: 1.09-
8.25) and G allele at rs2485893 (10kb 3’ of SYT14) were associated with NSCPO (p=0.0036, ORtransmission= 0.60, 
95%CI: 0.42-0.85). Genotypic TDT based on 3 pseudo controls further confirmed that rs742071 (p-value=0.03, 
ORtransmission=3.00, 95%CI: 1.09-8.25) and rs2485893 were associated with NSCPO under additive model (p-value= 
0.02, ORtransmission= 0.66, 95%CI: 0.47-0.92). Genotypic TDT for epistatic interactions showed that rs4844913 (37kb 
3’ of DIEXF) interacted with rs11119388 (SYT14) (p-value=1.80E-08) and rs6072081 (53kb 3’ of MAFB) inter-
acted with rs6102085 (33kb 3’ of MAFB) (p-value=3.60E-04) for NSCPO, suggesting they may act in the same 
pathway in the etiology of NSCPO. 
Conclusions: In this study, we found that rs742071 and rs2485893 were associated NSCPO from Han Chinese pop-
ulation; also, interactions of rs4844913:rs11119388 and rs6072081:rs6102085 for NSCPO were identified, gene-
gene interactions have been proposed as a potential source of the remaining heritability, these findings provided 
new insights of the previous GWAS.
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Introduction
Cleft palate (CP) is a common birth defect, which has 
a lower birth prevalence compared to cleft lip with/
without cleft palate (CL/P): 1/2500 live births vs. 1/700; 
but CP shows less variability in birth prevalence across 
populations compared to CL/P (1). 
In nonsyndromic cleft palate only (NSCPO), affected 
individuals have no other physical or developmental 
anomalies. Most studies suggest that about 50% of CP is 
nonsyndromic (2). Both population studies and family 
studies suggested that genetic factors played a critical 
role in the etiology of NSCPO (3,4). Among first degree 
relatives, the relative risks of recurrence risks were 56 
for cleft palate only and 32 for any cleft lip when com-
pared to the general population in Norway (3); several 
genes have been identified for syndromic forms of CP, 
few have been identified as influencing risk to NSCPO. 
The etiology of this complex trait has been widely stud-
ied in order to search for the risk factors and to design 
strategies for prevention.
Genome wide association studies entail the matching 
of a given human genome sequence with an annotated, 
high-resolution map of common genetic variation; They 
are contributing a lot to our understanding of diseases 
to which there is a genetic predisposition (5). Genome 
wide association studies (GWAS) already have identi-
fied tens of susceptible loci for cleft lip with or without 
cleft palate (CL/P).
However, whether these loci associated with nonsyndro-
mic cleft palate only for Han Chinese remains unknown. 
In this study, we replicated 38 SNPs from 19 genes/ re-
gions of 11 chromosomes from previous GWAS (6-10) 
and other studies (11-13) with prior compelling evidence 
contributing to NSCL/P to investigate their roles in Han 
Chinese population.
 
Material and Methods
- Samples
Our samples consisted of 144 complete case-parent trios 
with nonsydromic cleft palate only (NSCPO), 59 males, 
82 females and 3 unknown gender of the probands. All 
subjects were self-identified as Western Han Chinese, 
they were recruited between 2008 and 2013 from the 
Cleft Surgery Department of West China Hospital of 
Stomatology, Sichuan University. Written informed 
consent was obtained from parents on behalf of the 
children and all affected individuals old enough to give 
their own consent in this study. The consent procedure 
and this study approved by the Hospital Ethics Com-
mittee (HEC) of West China Hospital of Stomatology, 
Sichuan University. 
- Genotyping
Venous blood samples were drawn from participants 
and DNA was extracted by phenol chloroform extrac-
tion protocol. The SNP genotyping work was performed 
using a custom-by-design 2x48-Plex SNPscanTM Kit 
(Cat#:G0104, Genesky Biotechnologies Inc., Shanghai, 
China). 
- Statistical analysis 
The unaffected parents were underwent Hardy-Wein-
berg Equilibrium (HWE) analysis and minor allele 
frequency (MAF) determination. HWE, MAF, allelic 
TDT and parent-of-origin effects, were calculated using 
PLINK (14). Pairwise LD as both their D’ and r2 were 
computed for all the SNPs using the haploview program 
(http://www.broad.mit.edu/haploview/haploview). Ge-
notypic TDT and Likelihood ratio test for epistatic in-
teractions based on genotypic TDTs were determined 
with R Package trio (v1.4.23) (15), all two-way interac-
tions comprised a matrix in genotype format were test-
ed using the function colGxG, without specifying the 
genes, and the interactions between all 38 (38-1)/2 pairs 
of the SNPs in a matrix were tested. We used a Bonfer-
onni correction for 38 tests to determine a threshold for 
formal significance of p=0.0013.
 
Results
- Transmission Disequilibrium Test
All SNPs were passed the HWE test (p >0.05) (Table 
1). Allelic TDT results showed that T allele at rs742071 
(PAX7) (p=0.025, ORtransmission=3.0, 95%CI: 1.09-8.25) 
and G allele at rs2485893 (10kb 3’ of SYT14) were as-
sociated with NSCPO (p= 0.0036, ORtransmission= 0.60, 
95%CI: 0.42-0.85) (Table 2). Genotypic TDT based 
on 3 pseudo controls further confirmed that rs742071 
(p-value=0.03, ORtransmission=3.0, 95%CI: 1.09-8.25) and 
rs2485893 are associated with NSCPO under additive 
model (p-value=0.02, ORtransmission=0.66, 95%CI: 0.47-
0.92) (Table 3). 
- Parent-of-Origin Effects
There was no significant difference of minor allele 
transmissions between the maternal and paternal for all 
SNPs (data not shown). However, we found an excess 
of maternal transmission of the allele G at rs2485893 
(p=0.026), allele A at rs8001641 (p=0.018) and allele G 
at rs17563 (p=0.045) compared with the paternal (Table 
4), which might warrant future investigations.
- Gene by Gene Interactions
The Genotypic TDT for epistatic interactions showed 
that rs4844913 (43kb 3’ of DIEXF) interacted with 
rs11119388 (SYT14) (p=1.80E-08) and rs6072081 (53kb 
3’ of MAFB) interacted with rs6102085 (33kb 3’ of 
MAFB) (p= 3.60E-04) for NSCPO (Fig. 1). 
- Pair-wise Linkage Disequilibrium and Haplotype 
Analysis
We calculated the pair-wise linkage disequilibrium (LD) 
of SNPs on chromosome 1 based the association results 
above. There were strong LD between six pairs of SNPs 
(rs4920552-rs766325, rs126280-rs642961, rs2064163-
12063989, rs4844913-rs9429830, rs4844913-rs227178 
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CHR Gene SNP Position(Hg19) Location Minor Allele 
Major 
Allele MAF HWpval 
1 PAX7 rs4920522 18940380 Intergenic T C 0.22 0.38 
1 PAX7 rs766325 18956458 Upstream A G 0.19 0.85 
1 PAX7 rs6695765 18979320 Intronic C T 0.34 0.43 
1 PAX7 rs742071 18979874 Intronic T G 0.04 0.34 
1 ABCA4 rs560426 94553438 Intronic C T 0.32 0.69 
1 IRF6 rs2235371 209964080 Exon T C 0.45 0.55 
1 IRF6 rs642961 209989270 Upstream A G 0.19 0.34 
1 DIEXF rs126280 210019824 Intronic A G 0.19 1.00 
1 DIEXF rs2064163 210048819 Intergenic G T 0.50 0.81 
1 DIEXF rs12063989 210049893 Intergenic C T 0.48 1.00 
1 DIEXF rs4844913 210068117 Intergenic G A 0.38 0.90 
1 SYT14 rs9429830 210110537 Upstream C T 0.41 0.44 
1 SYT14 rs11119388 210174417 Intronic A G 0.49 0.48 
1 SYT14 rs227178 210216946 Intronic C T 0.35 0.20 
1 SYT14 rs2485893 210348155 Intergenic G A 0.38 0.45 
1 SLC25A24 rs6677101 108699730 Intronic T G 0.42 0.47 
2 THADA rs7590268 43540125 Intronic G T 0.04 0.34 
3 EPHA3 rs7632427 89534377 Downstream C T 0.17 0.68 
4 GRID2 rs12506428 93830884 Intronic T C 0.48 0.64 
8 DCAF4L2 rs12543318 88868340 Intergenic A C 0.35 0.90 
8 LOC728724 rs987525 129946154 Intergenic A C 0.09 0.71 
8 EPHX2 rs6558002 27389542 Intronic C T 0.14 0.23 
10 VAX1 rs7078160 118827560 Intronic A G 0.44 0.12 
10 VAX1 rs4752028 118834991 Intronic C T 0.33 0.43 
13 SPRY2 rs9574565 80668874 Intergenic T C 0.12 1.00 
13 SPRY2 rs8001641 80692811 Intergenic A G 0.16 0.83 
14 BMP4 rs17563 54417522 Exon G A 0.29 0.25 
15 FMN1 rs1258763 33050423 Downstream T C 0.08 0.67 
15 TPM1 rs7179658 63312695 Downstream C T 0.17 1.00 
17 NTN1 rs9788972 8919630 Upstream A G 0.20 0.27 
17 NTN1 rs9915089 8952894 Intronic T C 0.16 0.83 
17 NTN1 rs8081823 8965551 Intronic A G 0.41 0.47 
20 MAFB rs6072081 39261054 Intergenic G A 0.42 0.72 
20 MAFB rs6065259 39261979 Intergenic A G 0.40 0.14 
20 MAFB rs17820943 39268516 Intergenic T C 0.43 0.55 
20 MAFB rs13041247 39269074 Intergenic C T 0.43 0.63 
20 MAFB rs11698025 39274083 Intergenic A G 0.35 0.60 
20 MAFB rs6102085 39281629 Intergenic A G 0.45 0.34 
Table 1. Minor allele frequency and Hardy-Weinberg Equilibrium Test of the SNPs for NSCPO.
Note: CHR, chromosome; MAF, minor allele frequency; HWpval, p-values for Hardy-Weinberg Equilibrium test.
and rs9429830-227178) with D’>0.93 and r2>0.80, 
which distributed on two haplotypes (Fig. 2). Based on 
this, we tried to test if these pairs of SNPs segregate 
together among NSCPO by carrying out the haplotype 
analysis. The results did not show any significance (data 
not shown).
Discussion
Rs742071 is located in the intron of PAX7 which is in-
volved in neural crest induction and is expressed in cra-
nial neural crest cells, and mice lacking Pax7 have mal-
formations of the nasal and maxillary structures (16). 
The PAX7 was a second tier GWAS hit (8), later it was 
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Gene SNP Position(Hg19) A1 A2 T/U OR(95%CI) CHISQ P 
PAX7 rs4920522 18940380 T C 42/45 0.93(0.61-1.42) 0.10 0.75 
PAX7 rs766325 18956458 A G 44/41 1.07(0.70-1.64) 0.11 0.74 
PAX7 rs6695765 18979320 C T 68/59 1.15(0.81-1.63) 0.64 0.42 
PAX7 rs742071 18979874 T G 15/5 3.00(1.09-8.25) 5.00 0.025 
ABCA4 rs560426 94553438 C T 59/63 0.94(0.66-1.34) 0.13 0.72 
IRF6 rs2235371 209964080 T C 71/64 1.11(0.79-1.56) 0.36 0.55 
IRF6 rs642961 209989270 A G 41/39 1.05(0.68-1.63) 0.05 0.82 
DIEXF rs126280 210019824 A G 41/40 1.03(0.66-1.59) 0.01 0.91 
DIEXF rs2064163 210048819 G T 69/74 0.93(0.67-1.29) 0.17 0.68 
DIEXF rs12063989 210049893 C T 75/65 1.15(0.83-1.61) 0.71 0.40 
DIEXF rs4844913 210068117 G A 58/74 0.78(0.56-1.11) 1.94 0.16 
SYT14 rs9429830 210110537 C T 47/59 0.80(0.54-1.17) 1.36 0.24 
SYT14 rs11119388 210174417 A G 68/80 0.85(0.62-1.17) 0.97 0.32 
SYT14 rs227178 210216946 C T 59/78 0.76(0.54-1.06) 2.64 0.10 
SYT14 rs2485893 210348155 G A 51/85 0.60(0.42-0.85) 8.50 0.0036 
SLC25A24 rs6677101 108699730 T G 65/64 1.02(0.72-1.43) 0.01 0.93 
THADA rs7590268 43540125 G T 6/13 0.46(0.18-1.21) 2.58 0.11 
EPHA3 rs7632427 89534377 C T 33/44 0.75(0.48-1.18) 1.57 0.21 
GRID2 rs12506428 93830884 T C 65/79 0.82(0.59-1.14) 1.36 0.24 
DCAF4L2 rs12543318 88868340 A C 58/71 0.82(0.58-1.16) 1.31 0.25 
LOC728724 rs987525 129946154 A C 23/22 1.05(0.58-1.88) 0.02 0.88 
EPHX2 rs6558002 27389542 C T 44/31 1.42(0.90-2.25) 2.25 0.13 
VAX1 rs7078160 118827560 A G 66/58 1.14(0.80-1.62) 0.52 0.47 
VAX1 rs4752028 118834991 C T 58/62 0.94(0.65-1.34) 0.13 0.72 
SPRY2 rs9574565 80668874 T C 24/36 0.67(0.40-1.12) 2.40 0.12 
SPRY2 rs8001641 80692811 A G 44/30 1.47(0.92-2.33) 2.65 0.10 
BMP4 rs17563 54417522 G A 69/54 1.28(0.90-1.82) 1.83 0.18 
FMN1 rs1258763 33050423 T C 19/21 0.90(0.49-1.68) 0.10 0.75 
TPM1 rs7179658 63312695 C T 34/42 0.81(0.52-1.27) 0.84 0.36 
NTN1 rs9788972 8919630 A G 40/46 0.87(0.57-1.33) 0.42 0.52 
NTN1 rs9915089 8952894 T C 33/41 0.80(0.51-1.23) 0.86 0.35 
NTN1 rs8081823 8965551 A G 60/67 0.90(0.63-1.27) 0.39 0.53 
MAFB rs6072081 39261054 G A 68/64 1.06(0.76-1.50) 0.12 0.73 
MAFB rs6065259 39261979 A G 64/55 1.16(0.81-1.67) 0.68 0.41 
MAFB rs17820943 39268516 T C 71/60 1.18(0.84-1.67) 0.92 0.34 
MAFB rs13041247 39269074 C T 71/61 1.16(0.83-1.64) 0.76 0.38 
MAFB rs11698025 39274083 A G 63/55 1.15(0.80-1.65) 0.54 0.46 
MAFB rs6102085 39281629 A G 68/62 1.10(0.78-1.55) 0.28 0.60 
!
Table 2. Allelic TDT results of the SNPs for NSCPO.
Note: A1, Minor allele; A2, Major allele; T, minor allele transmitted, U, minor allele un-transmitted; OR, odds ratios for the transmis-
sions; 95%CI, 95% confidence interval. CHISQ, chi-square; P, p-values; Bold characters show the items with p values less than 0.01.
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Table 4. Parent-of-origin effect of effect of the SNPs.
Note: T: minor allele transmitted, U, minor allele untransmitted; CHISQ, chi-square; P, p-values; Z: vector of the large sample Z statistic; 
Bold characters show the items with p values less than 0.01.
Gene SNP Minor Allele 
Paternal Maternal 
Z P 
T/U CHISQ P T/U CHISQ P 
PAX7 rs4920522 T 26.5/24.5 0.08 0.78 15.5/20.5 0.69 0.40 0.82 0.41 
PAX7 rs766325 A 25.5/20.5 0.54 0.46 18.5/20.5 0.10 0.75 0.73 0.46 
PAX7 rs6695765 C 31.5/28.5 0.15 0.70 36.5/30.5 0.54 0.46 -0.22 0.82 
PAX7 rs742071 T 8.5/3.5 2.08 0.15 6.5/1.5 3.13 0.077 -0.52 0.60 
ABCA4 rs560426 C 31.5/25.5 0.63 0.43 27.5/37.5 1.54 0.21 1.43 0.15 
IRF6 rs2235371 T 30/35 0.38 0.54 41/29 2.06 0.15 -1.44 0.15 
IRF6 rs642961 A 22.5/22.5 0.00 1.00 18.5/16.5 0.11 0.74 -0.25 0.80 
DIEXF rs126280 A 22/23 0.02 0.88 19/17 0.11 0.74 -0.35 0.73 
DIEXF rs2064163 G 34/33 0.01 0.9 35/41 0.47 0.49 0.56 0.58 
DIEXF rs12063989 C 32/33 0.02 0.9 43/32 1.61 0.20 -0.96 0.34 
DIEXF rs4844913 G 32/37 0.36 0.55 26/37 1.92 0.17 0.59 0.56 
SYT14 rs9429830 C 23.5/30.5 0.91 0.34 23.5/28.5 0.48 0.49 -0.17 0.86 
SYT14 rs11119388 A 35.5/35.5 0.00 1.00 32.5/44.5 1.87 0.17 0.95 0.34 
SYT14 rs227178 C 31.5/37.5 0.52 0.47 27.5/40.5 2.49 0.11 0.62 0.54 
SYT14 rs2485893 G 27.5/43.5 3.61 0.058 23.5/41.5 4.99 0.026 0.31 0.76 
SLC25A24 rs6677101 T 35.5/30.5 0.38 0.54 29.5/33.5 0.25 0.61 0.79 0.43 
THADA rs7590268 G 3/5 0.50 0.48 3/8 2.27 0.13 0.47 0.64 
EPHA3 rs7632427 C 16.5/15.5 0.03 0.86 16.5/28.5 3.20 0.074 1.30 0.19 
GRID2 rs12506428 T 28/43 3.17 0.075 37/36 0.01 0.91 -1.35 0.18 
DCAF4L2 rs12543318 A 36/39 0.12 0.73 22/32 1.85 0.17 0.82 0.41 
LOC728724 rs987525 A 9/12 0.43 0.51 14/10 0.67 0.41 -1.03 0.30 
EPHX2 rs6558002 C 18.5/15.5 0.26 0.61 25.5/15.5 2.44 0.12 -0.68 0.50 
VAX1 rs7078160 A 34.5/23.5 2.09 0.15 31.5/34.5 0.14 0.71 1.31 0.19 
VAX1 rs4752028 C 31/23 1.19 0.28 27/39 2.18 0.14 1.79 0.073 
SPRY2 rs9574565 T 13/18 0.81 0.37 11/18 1.69 0.19 0.32 0.75 
SPRY2 rs8001641 A 22.5/21.5 0.02 0.88 21.5/8.5 5.63 0.018 -1.75 0.081 
BMP4 rs17563 G 33.5/33.5 0.00 1.00 35.5/20.5 4.02 0.045 -1.49 0.14 
!FMN1 rs1258763 T 11.5/12.5 0.04 0.84 7.5/8.5 0.06 0.8 0.06 0.95 
TPM1 rs7179658 C 21/21 0.00 1.00 13/21 1.88 0.17 1.02 0.31 
NTN1 rs9788972 A 17.5/26.5 1.84 0.17 22.5/19.5 0.21 0.64 -1.28 0.20 
NTN1 rs9915089 T 17/25 1.52 0.22 16/16 0.00 1.00 -0.82 0.42 
NTN1 rs8081823 A 32/32 0.00 1.00 28/35 0.78 0.38 0.63 0.53 
MAFB rs6072081 G 30/31 0.02 0.9 38/33 0.35 0.55 -0.50 0.62 
MAFB rs6065259 A 28.5/25.5 0.17 0.68 35.5/29.5 0.55 0.46 -0.20 0.84 
MAFB rs17820943 T 32/27 0.42 0.52 39/33 0.50 0.48 0.01 0.99 
MAFB rs13041247 C 32/28 0.27 0.61 39/33 0.50 0.48 -0.10 0.92 
MAFB rs11698025 A 26/25 0.02 0.89 37/30 0.73 0.39 -0.46 0.65 
MAFB rs6102085 A 34.5/29.5 0.39 0.53 33.5/32.5 0.02 0.90 0.36 0.72 
Table 4 continue. Parent-of-origin effect of effect of the SNPs.
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Fig. 2. Pair-wise Linkage Disequilibrium (A) and Haplotype (B) of SNPs at Chromosome 1. 
Fig. 1. Genotypic TDT for Epistatic Interactions of Pair-wise SNPs.
confirmed by replication among European and South-
east Asian (17) and GWAS meta-analysis (10). Recently, 
Leslie et al. 2015 performed targeted sequencing of 13 
regions from GWASs and other studies in 1,409 Asian 
and European trios, and carried out a series of statisti-
cal and functional analyses, the results indicated that de 
novo mutation p.Ala259Val disrupted PAX7 function 
and might contribute to CLP pathogenesis in this indi-
vidual (18). Although intronic SNPs do not typically al-
ter protein structure, associations with intronic variants 
have been reported for a number of complex diseases. 
In this study, we found rs742071 (PAX7) was associ-
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ated with NSCPO and had a larger genetic effects com-
pared with the associations with NSCL/P from previous 
GWASs (8,10); Motif analyses by HaploReg indicated 
that the T allele of rs742071 could greatly alter the af-
finity of Sin3Ak-20_disc4 (score: 2.1-14.1).  
Rs742071 had the minor allele frequency as 0.04 among 
Han Chinese population, indicating it may need larger 
sample size to validate its significance; and with the 
limited sample size, rs742071 did not pass the thresh-
old of the Bonferonni correction p value in the current 
study. We will add more samples to study it and other 
variants at PAX7 gene among NSCPO among Han Chi-
nese population. 
Rs2485893 was associated with CL/P among Asian an-
cestry with p value 7.86E-07 by GWAS (8). In this study, 
we found rs2485893 (10kb 3’ of SYT14) was also found 
to be associated with NSCPO. Marked parent of origin 
effects were seen for rs2485893 alleles, over-transmis-
sion was seen preferentially from mothers compared 
with fathers (Table 4). Motif analyses by HaploReg in-
dicated that the G allele of rs2485893 could greatly alter 
the affinity of AFP1 (score: 2.7-12.3).
Numerous studies have shown that highly conserved 
non-coding elements act as developmental enhancers 
in vivo (19-21). Non-coding conserved elements around 
rs742071 and rs2485893 therefore might represent puta-
tive regulatory elements for PAX7 and SYT14, we will 
perform functional studies to elucidate their roles in hu-
man craniofacial development.
Gene-gene interactions have been proposed as a po-
tential source of the remaining heritability. Genotypic 
TDT for epistatic interactions showed that rs4844913 
interacts with rs11119388 (SYT14) and rs6072081 inter-
acts with rs6102085 for NSCPO, which provided new 
insights for the previous GWASs.
In summary, we replicated 38 SNPs contributing to 
NSCL/P to investigate their roles in NSCPO among 
Han Chinese population. In this study, we found that 
rs742071 and rs2485893 were associated NSCPO 
from Han Chinese population; also, interactions of 
rs4844913:rs11119388 and rs6072081:rs6102085 for 
NSCPO were identified, which may provide new in-
sights for the previous GWASs.
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